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for food safety rules and human health 
risk measures taken by national health 
and veterinary agencies. Regarding ad-
equate processing of clinical samples 
and their preservation for morphologic 
and genetic evaluation, we strongly 
recommend fixation of positive fe-
cal samples with eggs or segments 
(proglottids) immediately with 96%–
99% molecular grade (i.e., not dena-
tured) ethanol for future molecular di-
agnosis (1,4,8).
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Drug Resistance in 
Salmonella enterica 
ser. Typhimurium 
Bloodstream  
Infection, Malawi
To the Editor: Salmonella en-
terica serotype Typhimurium is one 
of the most common causes of blood-
stream infection in sub-Saharan Africa 
(1). Among adults, the principal risk 
factor for invasive nontyphoidal Sal-
monella (iNTS) disease is advanced 
HIV infection; up to 44% of HIV-in-
fected patients experience bacteremic 
recurrence through recrudescence of 
the original infection (2,3). Epidemics 
of iNTS disease in sub-Saharan Africa 
have been associated with a novel gen-
otype of S. enterica ser. Typhimurium 
of multilocus sequence type (ST) 313 
that is rarely seen outside the region 
and is associated with multidrug resis-
tance (MDR) to chloramphenicol, co-
trimoxazole, and ampicillin (4,5). As a 
consequence, ceftriaxone has become 
a key agent in the empirical manage-
ment of nonfocal sepsis in Malawi (6).
In March 2009, a 40-year-old 
HIV-infected and antiretroviral thera-
py–naïve woman sought care in Blan-
tyre, Malawi, with an MDR S. en-
terica ser. Typhimurium bloodstream 
infection. She was treated with ceftri-
axone (2 g intravenously once daily) 
and discharged with oral ciprofloxacin 
(500 mg twice daily) for 10 days. She 
was readmitted 1 month later with re-
current fever. At this time, she had an 
MDR S. enterica ser. Typhimurium 
bloodstream infection with additional 
resistance to ceftriaxone and cipro-
floxacin. In the absence of a locally 
available effective antimicrobial drug, 
she was treated with ceftriaxone, gen-
tamicin, and high-dose ciprofloxacin 
but died shortly thereafter.
To help clarify how this extended 
MDR S. enterica ser. Typhimurium 
emerged, we determined the molecular 
mechanisms underpinning this disturb-
ing pattern of antimicrobial resistance 
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(online Technical Appendix, http://
wwwnc.cdc.gov/EID/article/20/11/14-
1175-Techapp1.pdf)). We conducted 
phenotypic drug susceptibility testing 
by disk diffusion on S. enterica ser. 
Typhimurium strains A54285 (initial 
presentation) and A54560 (recurrence); 
both isolates were resistant to ampicil-
lin, chloramphenicol, and cotrimoxa-
zole, but A54560 exhibited additional 
resistance to ceftriaxone, ciprofloxacin, 
and tetracycline.
Paired-end sequencing of iso-
lates A54285 (European Nucleotide 
Archive [ENA] accession number 
ERS035867) and A54560 (ENA ac-
cession no. ERS035866) that were 
cultured 1 month apart showed no 
differences between the conserved 
regions of these genomes (Figure). 
The similarity of these S. enterica ser. 
Typhimurium genomes strongly sug-
gests that this recrudescence occurred 
after incomplete clearance of the first 
infection; although re-infection from 
the same source is unlikely, it cannot 
be excluded. Comparison of the ac-
cessory genomes, however, showed 
an additional 300 kb DNA in A54560.
Plasmid extraction and gel elec-
trophoresis of genomic DNA identi-
fied a plasmid migrating in the gel to 
a position approximately equivalent to 
120 kb, the size of ST313 virulence 
plasmid pSLT-BT in both strains, but 
no 300-kb plasmid was visualized in 
the ceftriaxone- and ciprofloxacin-
resistant strain (A54560, data not 
shown), possibly because of the dif-
ficulty large plasmids have entering 
standard 1% agarose gels. However, 
ceftriaxone resistance was mobilized 
to Escherichia coli by conjugation 
at a frequency 6.5 × 10–2 transcon-
jugants per donor at 26°C. This fre-
quency dropped dramatically to ≈1 
×10–7 transconjugants per donor when 
conjugation was performed at 37°C. 
The presence of an IncHI2 plasmid 
in the transconjugants was confirmed 
by PCR for the IncHI2 region (7), and 
drug susceptibility testing confirmed 
that transconjugant clones acquired 
resistance to ceftriaxone, ciprofloxa-
cin, and tetracycline. 
These data confirm the presence 
of an extended-spectrum b-lactamase 
(ESBL)–producing IncHI2 plasmid in 
strain A54560 that is capable of con-
jugative transfer and suggest that the 
plasmid might have been acquired by 
residual index strain within the patient 
by transfer from an unknown donor 
Figure.	Midpoint-rooted	phylogenetic	 tree	of	published	whole-genome	sequence	data	 from	D23580-like	Salmonella enterica	 serotype	
Typhimurium	 sequence	 type	 313s	 from	 Malawi	 based	 on	 204	 informative	 single-nucleotide	 polymorphisms.	 A54285	 and	 A54560,	
highlighted	in	gray,	are	indistinguishable.	Scale	bar	indicates	nucleotide	substitutions	per	site.
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bacterium. Partial decolonization of 
the patient’s gastrointestinal tract by 
ceftriaxone and fluoroquinolone an-
timicrobial therapy might have ren-
dered it receptive to colonization by 
ESBL-producing bacteria, which we 
hypothesize donated the plasmid to 
the residual index strain.
The transconjugant plasmid DNA 
was sequenced by using the PacBio 
RSII platform (Pacific Biosciences, 
Menlo Park, CA, USA; http://www.
pacificbiosciences.com), which as-
sembled as a single contiguous se-
quence of 309,406 bp, designated 
pSTm-BTCR (online Technical Ap-
pendix Figure, ENA accession no. 
LK056646). We identified 331 pre-
dicted coding sequences, including 
109 genes required for replication and 
transfer and 61 genes predicted to be 
associated with metabolism, mem-
branes, virulence, antimicrobial resis-
tance, and a toxin/antitoxin addiction 
system. We found an additional 160 
predicted, hypothetical genes. Fifteen 
putative antimicrobial resistance genes 
were identified, predicted to encode 
resistance to; tetracycline (tetA(C), 
tetR(C)), b-lactams (bla
CTX-M15
, 
blaTEM-1b, blaOXA-30), chloramphenicol 
(catB3, catA1), aminoglycosides 
(strA, strB, aadA1, aacA4, aacC3), 
ciprofloxacin (qnrB1), ulfonamiides 
(sul2), and trimethoprim (dfrA14).
In our experience, ESBL and 
fluoroquinolone-resistant iNTS re-
main extremely uncommon in Blan-
tyre, Malawi. This is surprising be-
cause diverse ESBL genotypes were 
observed in other members of En-
terobacteriaceae in Blantyre within 
a year after ceftriaxone came into 
common use locally (8). That IncHI2 
plasmids transfer most efficiently at 
temperatures <30°C (9), a lower tem-
perature than in the human gastroin-
testinal tract, might explain why the 
acquisition of ESBL-producing en-
zymes through IncHI2 plasmids has 
not been commonly observed within 
patients with recurrent iNTS disease 
in this setting. However, rates of 
transfer might differ when bacteria 
are growing in the intestine.
The spread of mobile genetic 
elements that confer antimicrobial 
resistance among gram-negative or-
ganisms is of considerable concern. 
Wide dissemination of this strain or 
the IncHI2 (pSTm-BTCR) plasmid 
among other salmonellae in sub-Saha-
ran Africa would rapidly render iNTS 
effectively untreatable with currently 
available antibacterial drugs.
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